Navigation Links
Manchester leads green chemical training push
Date:1/20/2011

The University of Manchester is leading a 3.7m project to train the next generation of biotechnologists to make chemical processes greener.

The 'European biotechnology training network for the support of the chemical manufacturing industries' (BIOTRAINS) programme brings together microbiologists, enzymologists, chemists, engineers and process development experts involved in the training of the next generation of scientists who will develop green manufacturing methods for the chemical industry.

Led by Professor Nick Turner, Director of the Centre of Excellence for Biocatalysis, Biotransformations and Biocatalytic Manufacture (CoEBio3: www.coebio3.org), the four-year project involves eleven partners from academia and industry who will recruit and train research fellows and another six industrial partners who are offering placement training.

Funded by the European Union FP7 programme, the project is expected to make a major contribution to efforts to replace traditional chemical manufacturing reliant on highly toxic chemicals and solvents with so-called 'white biotechnology'.

White biotechnology employs the power of natural biocatalysts and modern manufacturing techniques to deliver safer and less-environmentally damaging industrial methods.

White biotechnology is a term used mainly in Europe for the application of nature's catalysts, such as enzymes and cells, in biotechnology for industrial purposes.

The use of the word 'white' distinguishes it from other biotechnologies such as 'red' (medicinal) and 'green' (plant) biotechnology.

The term covers the manufacturing of chemicals, alternative energy and biomaterials and has the potential to enable economies to become less dependent on fossil fuels.

At a recent project review meeting in Basel Professor Nick Turner said: "We have been fortunate to recruit some of the very best postgraduate students from our the world to participate in BIOTRAINS. The pr
'/>"/>

Contact: Daniel Cochlin
daniel.cochlin@manchester.ac.uk
44-161-275-8387
University of Manchester
Source:Eurekalert

Page: 1 2

Related biology news :

1. University of Manchester academics at international conference on geographic chemicals
2. Opportunity leads to promiscuity among squirrels, study finds
3. Social stress leads to atherosclerosis
4. Research provides new leads in the case against drug-resistant biofilms
5. BOEMRE leads study of deepwater communities post-Deepwater Horizon spill
6. OU study on genetics in fruit flies leads to new method for understanding brain function
7. Marine Pied Piper leads Nemo astray
8. Artificially controlling water condensation leads to room-temperature ice
9. Rapid growth in adolescence leads to fewer offspring, UC Riverside biologists find
10. Barrow scientist leads insula research
11. Gene leads to longer shelf life for tomatoes, possibly other fruits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... Growers of annual bedding plant seedlings or plugs ... a large stem diameter and high root dry ... during shipping and transplant. To achieve these desirable ... on supplemental lighting from high-pressure sodium lamps during ... diodes (LEDs) can give greenhouse growers other lighting ...
(Date:7/21/2014)... their cells are stressed when facing temperature extremes. Worse ... in the cell are slowed down more than others, ... of whack. Yet, those cells manage to keep their ... Rochester and the European Molecular Biology Laboratory have found ... of proteins is a key process in all cells, ...
(Date:7/20/2014)... A study of 473 sets of twins followed since ... of 24-month-old identical twins had language delay compared to ... the rate of late language emergence of single-born children. ... , The results of the study were published in ... Hearing Research . , University of Kansas Distinguished ...
Breaking Biology News(10 mins):LEDs shine in bedding plant production study 2When temperatures get cold, newly-discovered process helps fruit flies cope 2Large twin study suggests that language delay due more to nature than nurture 2Large twin study suggests that language delay due more to nature than nurture 3
... things that exist underground, plant roots are out-of-sight and ... plant parts are more familiar, plant roots are equally ... crop, and dazzling ornamental lies a root system that ... for plants, extract water and nutrients from soil, and ...
... Since the terrorist attacks of 2001, the Bureau of ... water and power to millions of people, has invested ... protect its facilities and personnel, says a new report ... better communication among security staff, regional and area office ...
... WI, AUGUST 18, 2008 Serpentine soils contain highly ... farming. Successful management of serpentine soils requires accurate measurement ... in the Soil Science Society of America Journal ... accurately measure calcium content in serpentine soils. To ...
Cached Biology News:Getting to the root of the matter 2National Research Council report on security at federally managed dams 2National Research Council report on security at federally managed dams 3
(Date:7/20/2014)... NY (PRWEB) July 20, 2014 ... custom quartz glass optics, and spectrophotometer calibration ... these years, NSG has released many products that ... successful product has been their solid-state calibration standards. ... liquid standards since their release in 2008. ...
(Date:7/18/2014)... 2014 Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced ... and operating results on Tuesday, August 5, 2014, before ... a conference call and simultaneous webcast at 8:30 AM ... InformationTo access this call, dial (888) 660-6127 (U.S.) or ... be accessed from the ,Events and Presentations, page of ...
(Date:7/18/2014)... Researchers at the University of Illinois at Urbana-Champaign ... pillar-bowtie nanoantennas (pBNAs) can be used like traditional ... are much smaller than the wavelength of light ... red light). A standard optical microscope acts as ... film. , "Unlike conventional photographic film, the effect ...
(Date:7/18/2014)... Reflecting the importance of the evolution of ... Rankin, the founder and president of Customized Real ... a fresh new approach to the firm’s branding. , ... influence the success of his or her commercial clients have ... of the first in this market to fully embrace the ...
Breaking Biology Technology:How NSG Precision Cells Spectrophotometer Calibration Standards Makes NIR Work Easier 2How NSG Precision Cells Spectrophotometer Calibration Standards Makes NIR Work Easier 3'Nanocamera' takes pictures at distances smaller than light's own wavelength 2LEED AP Certified ITRA Global / Customized Real Estate Services Introduces New Approach to Its Branding 2
... N.J., Nov. 4 Cambrex,Corporation (NYSE: CBM ) reports third ... (Logo: http://www.newscom.com/cgi-bin/prnh/20000613/CAMBREXLOGO ), -- Sales increased ... third quarter 2007. -- Adjusted EBITDA for the quarter was ... $9.7 million last year. -- Debt, net of cash was ...
... - Oncolytics Biotech Inc.,("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced ... pursue a pivotal (Phase II/III) randomized trial ... refractory,patients with head and neck cancers. The ... by the Company,s Board of Directors from ...
... Md., Nov. 4 PharmAthene, Inc.,(NYSE Alternext US: ... and chemical threats, announced today,that David P. Wright, ... at the Rodman and Renshaw 10th Annual Healthcare ... beginning at 2:25 p.m. E.T. in the,Holmes II ...
Cached Biology Technology:Cambrex Reports Third Quarter 2008 Results 2Cambrex Reports Third Quarter 2008 Results 3Cambrex Reports Third Quarter 2008 Results 4Cambrex Reports Third Quarter 2008 Results 5Cambrex Reports Third Quarter 2008 Results 6Cambrex Reports Third Quarter 2008 Results 7Cambrex Reports Third Quarter 2008 Results 8Cambrex Reports Third Quarter 2008 Results 9Cambrex Reports Third Quarter 2008 Results 10Cambrex Reports Third Quarter 2008 Results 11Cambrex Reports Third Quarter 2008 Results 12Cambrex Reports Third Quarter 2008 Results 13Cambrex Reports Third Quarter 2008 Results 14Oncolytics Biotech Inc. Announces Decision to Pursue Phase II/III Pivotal Clinical Trial 2